REVELATION BIOSCIENCES, INC.

REVB ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	Feb 13, 2025	4
4	Feb 13, 2025	4
8-K	Feb 11, 2025	8-K
8-K	Jan 30, 2025	8-K
8-K	Jan 21, 2025	8-K
DEFA14A	Jan 13, 2025	DEFA14A
8-K	Jan 7, 2025	8-K
SCHEDULE 13G/A	Jan 2, 2025
EFFECT	Dec 20, 2024
424B3	Dec 20, 2024	424B3
CORRESP	Dec 20, 2024
CORRESP	Dec 19, 2024
S-3/A	Dec 19, 2024	S-3/A
UPLOAD	Dec 18, 2024
DEF 14A	Dec 16, 2024	DEF 14A
8-K	Dec 12, 2024	8-K
S-3	Dec 12, 2024	S-3
8-K	Dec 6, 2024	8-K
PRE 14A	Dec 5, 2024	PRE 14A
8-K	Nov 8, 2024	8-K
10-Q	Nov 8, 2024	10-Q
8-K	Oct 21, 2024	8-K
8-K	Sep 27, 2024	8-K
UPLOAD	Sep 25, 2024
10-Q/A	Sep 23, 2024	10-Q/A

← Newer Page 5 of 16 · 387 filings Older →